LEVIN JEREMY M 4
4 · Ovid Therapeutics Inc. · Filed Feb 26, 2019
Insider Transaction Report
Form 4
LEVIN JEREMY M
DirectorCEO
Transactions
- Purchase
Common Stock
2019-02-22$2.00/sh+75,000$150,000→ 4,676,529 total - Award
Employee Stock Option (Right to Buy)
2019-02-24+250,000→ 250,000 totalExercise: $1.89Exp: 2029-02-23→ Common Stock (250,000 underlying)
Holdings
- 35,461(indirect: See Footnote)
Common Stock
- 465,116(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse in the manager of Divo. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.
- [F2]The reportable securities are owned directly by DSL-EAL Holdings LLC (the "LLC"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein.
- [F3]25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.